DERMALIZE
Live / Applied — Opposition pending (as of 23 Apr 2024)
What this means for you
Not registered yet, but its 01 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers. An opposition to it is pending before the Trademark Trial and Appeal Board, so it will register only if the opposition fails or is withdrawn.
Record
- Serial number
- 97817486
- Mark type
- Word mark
- Filed
- 01 Mar 2023
- Published for opposition
- 09 Jan 2024
- Attorney of record
- JEFFERY M LILLYWHITE
Goods and services
- Class 003 — Cosmetics and cleaning preparations: Non-medicated soaps for tattoo aftercare; Non-medicated skin care preparations, namely, creams, lotions, and cleaners for tattoo aftercare
- Class 005 — Pharmaceuticals: Adhesive bandages; Medical dressings for tattoo aftercare; Wound dressings
Owner
- Saniderm Medical, LLC, Lehi, UT, US
- Saniderm Medical, LLC, Lehi, UT, US
Board proceedings on this mark
- Opposition No. 91291087 — D-Lize srl v. Saniderm Medical, LLC, filed 23 Apr 2024 (Suspended)
- Extension of Time to Oppose No. 97817486 — D-Lize srl v. Saniderm Medical, LLC, filed 06 Feb 2024 (Terminated)
Prosecution history
- 13 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 13 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 08 May 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 23 Apr 2024 — OPPOSITION INSTITUTED NO. 999999
- 06 Feb 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 09 Jan 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jan 2024 — PUBLISHED FOR OPPOSITION
- 20 Dec 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Dec 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Dec 2023 — EXAMINER'S AMENDMENT ENTERED
- 04 Dec 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2023 — EXAMINERS AMENDMENT E-MAILED
- 04 Dec 2023 — EXAMINERS AMENDMENT -WRITTEN
- 30 Nov 2023 — LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN